Education
About Us
Working with TipRanks
Follow Us
BLES - AI Analysis
Top Page
Inspire Global Hope ETF (BLES)
Rating:59Neutral
Price Target:
$45.00
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid gains so far this year, indicating strong overall momentum.
Global Diversification
The fund invests in companies across multiple countries, reducing reliance on any single geographic market.
Broad Sector Exposure
With investments spread across industries like Industrials, Technology, and Financials, the ETF benefits from diversified sector exposure.
Negative Factors
High Expense Ratio
The ETF charges a relatively high fee compared to many passive funds, which can eat into investor returns over time.
Underperforming Holdings
Some top holdings, such as Sarepta Therapeutics and JB Hunt, have struggled recently, potentially dragging on the fund's performance.
U.S.-Heavy Allocation
Over half of the fund's assets are concentrated in U.S. companies, limiting exposure to faster-growing international markets.
BLES vs. SPDR S&P 500 ETF (SPY)
AUM125.82M
RegionGlobal
Expense Ratio0.58%
Beta0.79
IssuerInspire
Inception DateFeb 27, 2017
Dividend Yield1.66%
Asset ClassEquity
Index TrackedInspire Global Hope Large Cap Equal Weight Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume5,872
30 Day Avg. Volume10,254
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
47.81Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering406
BLES Summary
The Inspire Global Hope ETF (Ticker: BLES) is an investment fund that focuses on large-cap companies worldwide, combining financial performance with a commitment to ethical and positive global impact. It includes well-known companies like Bloom Energy and Sarepta Therapeutics, and invests across sectors such as technology, healthcare, and industrials. This ETF is ideal for investors who want to diversify their portfolio while supporting socially responsible businesses. However, new investors should be aware that its performance can fluctuate with the broader market, as it is tied to large-cap stocks globally.
How much will it cost me?The Inspire Global Hope ETF (Ticker: BLES) has an expense ratio of 0.58%, which means you’ll pay $5.80 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on ethical and values-based investments that require more research and oversight.
What would affect this ETF?The Inspire Global Hope ETF (BLES) could benefit from global economic growth and increased interest in socially responsible investing, as its focus on ethical large-cap companies aligns with growing investor demand for values-based strategies. However, potential risks include sector-specific challenges, such as volatility in technology and financial industries, and broader economic uncertainties like rising interest rates or geopolitical tensions that could impact global markets. The ETF’s diversified sector exposure and global focus provide stability, but its performance may be influenced by shifts in investor sentiment or regulatory changes affecting its top holdings.
BLES Top 10 Holdings
The Inspire Global Hope ETF (BLES) showcases a diverse global portfolio with a tilt toward industrials and technology, but its performance has been a mixed bag recently. Bloom Energy is rising steadily, buoyed by strong earnings and strategic developments, while Vertiv Holdings also shows promise with robust revenue growth and profitability. On the other hand, Sarepta Therapeutics is lagging due to financial challenges and product adoption hurdles. Meanwhile, Hang Seng Bank provides steady income-focused appeal, and Super Micro Computer delivers solid growth despite margin pressures. Overall, the fund balances ethical investing with large-cap stability, though sector dynamics remain key to its trajectory.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Bloom Energy | 0.44% | $552.03K | $33.67B | 1215.80% | 68 Neutral | |
| Advantest | 0.36% | $453.07K | ¥16.93T | 160.48% | 67 Neutral | |
| Sarepta Therapeutics | 0.35% | $437.97K | $2.39B | -80.13% | 54 Neutral | |
| Teradyne | 0.33% | $416.05K | $28.67B | 75.57% | 76 Outperform | |
| Vertiv Holdings | 0.33% | $413.68K | $73.18B | 80.21% | 78 Outperform | |
| NEXTracker, Inc. Class A | 0.33% | $408.73K | $15.06B | 141.90% | 80 Outperform | |
| Roivant Sciences | 0.32% | $407.02K | $13.38B | 69.99% | 58 Neutral | |
| AEON Co | 0.32% | $405.40K | ¥6.76T | 92.28% | 65 Neutral | |
| Ciena | 0.32% | $405.10K | $26.74B | 199.75% | 70 Outperform | |
| Hang Seng Bank | 0.32% | $397.62K | HK$284.12B | 32.07% | 76 Outperform |
BLES Technical Analysis
Positive
―
Price Trends
42.38
Positive
41.61
Positive
39.69
Positive
Market Momentum
0.13
Positive
50.31
Neutral
15.22
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BLES, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 42.67, equal to the 50-day MA of 42.38, and equal to the 200-day MA of 39.69, indicating a neutral trend. The MACD of 0.13 indicates Positive momentum. The RSI at 50.31 is Neutral, neither overbought nor oversold. The STOCH value of 15.22 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BLES.
BLES Peer Comparison
Comparison Results
Performance Comparison
BLES
Inspire Global Hope ETF
42.64
4.65
12.24%
TGRW
T. Rowe Price Growth Stock ETF
―
―
―
FFLC
Fidelity Fundamental Large Cap Core ETF
―
―
―
FHEQ
Fidelity Hedged Equity ETF
―
―
―
FFLG
Fidelity Fundamental Large Cap Growth ETF
―
―
―
TEQI
T. Rowe Price Equity Income ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents